Axsome Therapeutics Inc (AXSM)

07:40 AM

Axsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote & History - Yahoo Finance

07:40 AM

07:00 AM

Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting - Yahoo Finance

07:00 AM

May 24, 2026

Axsome Therapeutics, Inc. $AXSM Shares Acquired by Legato Capital Management LLC - MarketBeat

May 24, 2026

May 22, 2026

Axsome Therapeutics stock hits all-time high at 236.84 USD By Investing.com - Investing.com Nigeria

May 22, 2026

May 22, 2026

Axsome Therapeutics Climbs Higher On Nasdaq Momentum - Kalkine Media

May 22, 2026

May 22, 2026

Technical Reactions to AXSM Trends in Macro Strategies - Stock Traders Daily

May 22, 2026

May 22, 2026

Axsome Therapeutics (NASDAQ:AXSM) Reaches New 1-Year HighShould You Buy? - MarketBeat

May 22, 2026

May 22, 2026

Axsome Therapeutics stock hits all-time high at 236.84 USD - Investing.com

May 22, 2026

May 22, 2026

AXSM Stock Price, Quote & Chart | AXSOME THERAPEUTICS INC (NASDAQ:AXSM) - ChartMill

May 22, 2026

May 21, 2026

Axsome wins FDA label expansion for Auvelity in Alzheimer’s agitation - MSN

May 21, 2026

May 21, 2026

AXSM Technical Analysis | Trend, Signals & Chart Patterns | AXSOME THERAPEUTICS INC (NASDAQ:AXSM) - ChartMill

May 21, 2026

May 19, 2026

AXSM: June launch of new Alzheimer's agitation drug, expanded sales force, and robust pipeline progress - TradingView

May 19, 2026

May 18, 2026

Axsome Therapeutics (AXSM) price target increased by 18.66% to 272.70 - MSN

May 18, 2026

May 18, 2026

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: High Growth Potential with 18.69% Upside - DirectorsTalk Interviews

May 18, 2026

May 17, 2026

Why is Axsome (AXSM) down 6.6% since last earnings report? - MSN

May 17, 2026

May 17, 2026

Axsome projects Auvelity peak sales of at least $8B following Alzheimer's agitation approval and June launch - MSN

May 17, 2026

May 17, 2026

AXSM stock clocks best day in about 4 months on FDA greenlight for Alzheimer’s drug - MSN

May 17, 2026

May 16, 2026

Axsome Therapeutics bets on AUVELITY expansion with June Alzheimer's agitation launch - MSN

May 16, 2026

May 14, 2026

Axsome stock climbs on schizophrenia drug deal with Takeda - MSN

May 14, 2026

May 14, 2026

Axsome's Auvelity: A New Treatment For Agitation In Alzheimer's Disease (AXSM) - Seeking Alpha

May 14, 2026

May 14, 2026

AXSM Stock Chart | AXSOME THERAPEUTICS INC (NASDAQ:AXSM) - ChartMill

May 14, 2026

May 13, 2026

Axsome Therapeutics stock hits all-time high at 234.57 USD - Investing.com India

May 13, 2026

May 13, 2026

Axsome Therapeutics stock hits all-time high at 234.57 USD By Investing.com - Investing.com Nigeria

May 13, 2026

May 13, 2026

AXSM stock is rising today after Wall Street’s positive stance despite mixed Q1 – what's behind the optimism? - MSN

May 13, 2026

May 12, 2026

Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch - sharewise.com

May 12, 2026

May 12, 2026

Piper Sandler Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $258 - Moomoo

May 12, 2026

May 12, 2026

Strong drug sales lift Axsome revenue, but profit miss drags stock - MSN

May 12, 2026

May 11, 2026

Trading the Move, Not the Narrative: (AXSM) Edition - Stock Traders Daily

May 11, 2026

May 11, 2026

White & Case advises Takeda on divestment to Axsome Therapeutics - White & Case LLP

May 11, 2026

May 11, 2026

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Understanding the 24% Potential Upside in CNS Treatments - DirectorsTalk Interviews

May 11, 2026

May 10, 2026

Axsome Q1 2026 slides: 57% revenue surge, $18B peak sales target - Investing.com Nigeria

May 10, 2026

May 10, 2026

Axsome Q1 2026 slides: 57% revenue surge, $18B peak sales target By Investing.com - Investing.com South Africa

May 10, 2026

May 10, 2026

Earnings call transcript: Axsome Therapeutics Q1 2026 reveals mixed results By Investing.com - Investing.com Australia

May 10, 2026

May 10, 2026

Earnings call transcript: Axsome Therapeutics Q1 2026 reveals mixed results - Investing.com

May 10, 2026

May 10, 2026

The week in pharma: action, reaction and insight – week to May 8, 2026 - The Pharma Letter

May 10, 2026

May 10, 2026

Axsome Therapeutics, Inc. $AXSM Holdings Decreased by State of New Jersey Common Pension Fund D - MarketBeat

May 10, 2026

May 08, 2026

Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $310 - Moomoo

May 08, 2026

May 08, 2026

3 Stocks Poised to Disrupt the Healthcare Market by 2030 - The Motley Fool

May 08, 2026

May 08, 2026

Principal Financial Group Inc. Lowers Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

May 08, 2026